Ex vivo expansions and transplantations of mouse bone marrow-derived hematopoietic stem/progenitor cells

Journal of Zhejiang University: Science

Volumn 5, Issue 2, 2004, Pages 157-163

  Wang, Jin Fu ^a   Wu, Yi Fan ^a   Harrintong, Jenny ^b   McNiece, Ian K ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Expansion; Hematopoietic stem cells; Mesenchymal stem cells; Transplantation

Indexed keywords

ANIMAL CELL CULTURE; BLOOD; BONE; EXPANSION;

EX VIVO EXPANSIONS; MARROW DERIVED HEMATOPOIETIC STEM CELLS; MESENCHYMAL STEM CELLS; MONONUCLEAR CELLS;

TRANSPLANTATION (SURGICAL);

ANIMAL; ARTICLE; COCULTURE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; MONONUCLEAR CELL; MOUSE; SURVIVAL; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; COCULTURE TECHNIQUES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; LEUKEMIA, RADIATION-INDUCED; LEUKOCYTES, MONONUCLEAR; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 2342438850     PISSN: 10093095     EISSN: None     Source Type: Journal    
DOI: 10.1631/jzus.2004.0157     Document Type: Article

References (16)

1. Faucher, C., Le Corroller, A.G., Blaise, D., Novakovitch, G., Manonni, P., 1994. Comparison of GCSF-promed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness. Bone Marrow Transplant, 14: 895-901.
2. Glaspy, J.A., Shpall, E.J., LeMaistre, C.F., Briddell, R.A., Menchaca, D.M., Turner, S.A., Lill, M., Chap, L., Jones, R., Wiers, M.D., Sheridan, W.P., McNiece, I.K., 1997. Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood, 90: 2939-2951.
3. Gluckman, E., Rocha, V., Boyer-Chammard, A., Locatelli, F., Arcese, W., Pasquini, R., Ortega, J., Souillet, G., Ferreira, E., Laporte, J.P., Fernandez, M., Chastang, C., 1997. Outcome of cord-blood transplantation from related and unrealated donors. TV Engl J Med, 337: 373-381.
4. Hartmann, O., Le Corroller, A.G., Blaise, D., Michon, J., Philip, I., Norol, F., Janvier, M., Pico, J.L., Baranzelli, M.C., Rubie, H., Coze, C., Pinna, A., Meresse, V., Benhamou, E., 1997. Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. Ann Intern Med, 126: 600-607.
5. + cells. Blood, 94 (sup.): 554a.
6. McNiece, I., Jones, R., Bearman, S.I., Cagnoni, P., Nieto, Y., Franklin, W., Ryder, J., Steele, A., Stoltz, J., Russell, P., McDermitt, J., Hogan, C., Murphy, J., Shpall, E.J., 2000a. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood, 96: 3001-3007.
7. McNiece, I.K., Kubegov, D., Kerzic, P., Shpall, E.J., Gross, S., 2000b. Increased expansion and differentiation of cord blood products using a two-step expansion culture. Experi. Hematol., 28: 1181-1186.
8. Paquette, R.L., Dergham, S.T., Karpf, E., Wang, H.J., Slamon, D.J., Souza, L., Glaspy, J.A., 2000. Ex vivo expanded unselected peripheral blood progenitor cells reduce post transplant neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood, 96: 2385-2390.
9. Paquette, R.L., Dergham, S.T., Karpf, E., Wang, H.J., Slamon, D.J., Souza, L., Glaspy, J.A., 2002. Culture conditions affect the ability of ex vivo expanded peripheral blood progenitor cells to accelerate hematopoietic recovery. Experi. Hematol., 30: 374-380.
10. Peters, W.P., Shpall, E.J., Jones, R.B., Olsen, G.A., Bast, R.C., Gockerman, J.P., Moore, J.O., 1988. High-dose combination alkylating agents with bone marrow support as an initial treatment for metastatic breast cancer. J Clin Oncol, 6: 1368-1376.
11. Reiffers, J., Cailliot, C., Dazey, B., Attal, M., Caraux, J., Boiron, J.M., 1999. Abrogation of post-myeloablative chemotherapy neutropenia by ex vivo expanded auto-logous CD34-positive cells. Lancet, 354: 1092-1093.
12. Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.M., Boogaerts, M.A., Ferrant, A., Demuynck, H.M., Link, H., Zander, A., Barge, A., 1996. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet, 347: 353-357.
13. Sheridan, W., Begley, C., Juttner, C., Szer, J., To, L.B., Maher, D., McGrath, K.M., Morstyn, G., Fox, R.M., 1992. Effect of peripheral blood progenitor cells mobilized by figrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet, 339: 640-644.
14. Shpall, E.J., Quinones, R., Jones, R., Zeng, C., Baron, A.E., Jones, R.B., Bearman, S.I., Nieto, Y., Freed, B., Madinger, N., Hogan, C.J., Slat-Vasquez, V., Russell, P., Blunk, B., Schissel, D., Hild, E., Malcolm, J., Ward, W., McNiece, I.K., 1999. Transplantation of adult and pediatric cancer patients with cord blood progenitors expanded ex vivo. Blood, 94(sup.): 712a.
15. To, L.B., Roberts, M.M., Haylock, D.N., Dyson, P.G., Branford, A.L., Thorp, D., Ho, J.Q., Dart, G.W., Horvath, N., Davy, M.L., 1992. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant, 9: 277-284.
16. Wang, J.F., Wang, L.J., Harrintong, J., McNiece, I.K., 2003. Effects of bone marrow-derived mesenchymal stem cell layer on expansion and differentiation of hematopoietic stem cells from cord blood. J Zhejiang University-SCIENCE, 30: 93-97(in Chinese).